Simultaneous determination of rifampicin and sulbactam in mouse plasma by high-performance liquid chromatography

被引:11
作者
Aparicio, Irene [1 ]
Bello, Miguel Angel [1 ]
Callejon, Manuel [1 ]
Guiraum, Alfonso [1 ]
机构
[1] Univ Seville, Dept Analyt Chem, Seville 41011, Spain
关键词
rifampicin; sulbactam; high-performance liquid chromatography (HPLC); mouse plasma;
D O I
10.1002/bmc.591
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple and rapid high-performance liquid chromatographic (HPLC) method with ultraviolet detection has been developed and validated for the simultaneous determination of rifampicin and sulbactam in mouse plasma. Plasma samples were deproteinized with acetonitrile and separated by HPLC on a RP-18 (125 x 4 mm, 5 mu m) column and gradient elution with potassium dihydrogen phosphate solution (pH 4.5; 50 mM) and acetonitrile at a flow-rate of 1.0 mL/min. Rifampicin and sulbactam were monitored at 230 nm and confirmed by means of their UV spectra using a diode-array detector. The method was linear at plasma levels from 1 to 100 mu g/mL for rifampicin and from 5 to 200 mu g/mL for sulbactam. The limits of quantification were 0.6 mu g/mL for rifampicin and 4.2 mu g/mL for sulbactam. The intra- and inter-day precisions of the method (RSD) were lower than 5% for both compounds. Average recoveries of rifampicin and sulbactam from mice plasma were 98.2 and 89.3%, respectively. The developed method was successfully applied to the determination of the pharmacokinetic profile of both compounds in mice. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:748 / 752
页数:5
相关论文
共 7 条
[1]  
[Anonymous], 1996, Q2B ICH EUR AG EV ME
[2]   In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak [J].
Appleman, MD ;
Belzberg, H ;
Citron, DM ;
Heseltine, PNR ;
Yellin, AE ;
Murray, J ;
Berne, TV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :1035-1040
[3]  
PACHONIBANEZ ME, 2005, CLIN MICROBIOL INFEC, V11, P577
[5]   Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii -: J Antimicrob Chemother 1998; 42:270-271 [J].
Tascini, C ;
Menichetti, F ;
Bozza, S ;
Del Favero, A ;
Bistoni, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :270-271
[6]   Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii [J].
Urban, C ;
Segal-Maurer, S ;
Rahal, JJ .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (10) :1268-1274
[7]   In vivo efficacies of combinations of β-lactams, β-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model [J].
Wolff, M ;
Joly-Guillou, ML ;
Farinotti, R ;
Carbon, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1406-1411